NETRF-funded research may help predict pancreatic neuroendocrine tumor (pNET) recurrence
IMAGE: Dr. Ramesh Shivdasani finds a clinical marker for non-functional pancreatic neuroendocrine tumor metastasis view more Credit: Dana-Farber Cancer Center A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may help predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not release excess hormones into the bloodstream. In…